The global inclusion body myositis (IBM) market is expected to grow at a significant CAGR during the forecast period. Muscle weakness and damage are caused by inclusion body myositis, a rare condition. IBM symptoms include progressive weakness in the muscles of the hand, forearm, thigh, and lower leg, but these symptoms vary and are not unique to this condition. The increasing prevalence of IBM around the world is a major factor driving demand for the global Inclusion body myositis market. IBM affects males slightly more often than females. Its prevalence is estimated to be between 10-112 people per 1,000,000 in the general population. It occurs with greater frequency in individuals more than 50 years of age. The prevalence is estimated to be 51-139 per 1,000,000 individuals in the general population over 50, making IBM the most common acquired muscle disorder (myopathy) in that age group.
Browse the full report description of “Global Inclusion Body Myositis Market Size, Share, and Trends, By Type (ACE-083, Aceneuramic Acid ER, ALZ-1903, UX-001P, UX-007, and Others), By End-User (Hospital, Clinic, and Others), Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/inclusion-body-myositis-market
Significant Investment funding for the development of new therapy to treat IBM is expected to offer lucrative growth opportunities to the market. For instance, in March 2020, AAVogen, an early-stage biotech company, raised $2.3 million mostly from NIH grants, and is now seeking another $2-3 million in seed funding for the development of AVGN7, a novel gene therapy treatment for IBM.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
? By Type
? By Application
• Regions Covered-
? North America
? Europe
? Asia-Pacific
? Rest of the World
• Competitive Landscape- Abcuro, Inc., Acceleron Pharma Inc., Kpi Therapeutics Inc., Orphazyme Aps, Nobelpharma Co Ltd., among others
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
The Global Inclusion Body Myositis Market Report by Segment
By Type
By Application
The Global Inclusion Body Myositis Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/inclusion-body-myositis-market